Evidence map›Paper›PMID 25311616›Full record

ArticleJournal of proteome research2014

Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling.

Anya Alayev, Peter F Doubleday, Sara Malka Berger, Bryan A Ballif, Marina K Holz

Abstract read
In one paragraph

Article in Journal of proteome research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. O-methylation of phenolic natural products: translational insights from resveratrol.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Resveratrol as a cardioprotective adjuvant for 5-fluorouracil in the treatment of gastric cancer cells.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  7. Review
  8. Crosstalk between Resveratrol and Gut Barrier: A Review.International journal of molecular sciences · 2022
    Review
  9. Review
  10. CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity.Journal of experimental & clinical cancer research : CR · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Anya AlayevDepartment of Biology, Stern College for Women of Yeshiva University , New York, New York 10016, United States.
Peter F Doubleday
Sara Malka Berger
Bryan A Ballif
Marina K Holz
University of Vermont · USYeshiva University · USAlbert Einstein College of Medicine · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
The role of the mTOR signaling pathway in ER-positive breast cancerR15CA151112 · NCI · YESHIVA UNIVERSITY · PI HOLZ, MARINA K · 2010 to 2013
$951k
NCI NIH HHS CA151112NCI NIH HHS R15 CA151112NIGMS NIH HHS P20 GM103449PHS HHS NIHNIGMS/INBRE 8P20GM103449
6 · The paper itself

Abstract

Resveratrol, a plant-derived polyphenol, regulates many cellular processes, including cell proliferation, aging and autophagy. However, the molecular mechanisms of resveratrol action in cells are not completely understood. Intriguingly, resveratrol treatment of cells growing in nutrient-rich conditions induces autophagy, while acute resveratrol treatment of cells in a serum-deprived state inhibits autophagy. In this study, we performed a phosphoproteomic analysis after applying resveratrol to serum-starved cells with the goal of identifying the acute signaling events initiated by resveratrol in a serum-deprived state. We determined that resveratrol in serum-starved conditions reduces the phosphorylation of several proteins belonging to the mTORC1 signaling pathway, most significantly, PRAS40 at T246 and S183. Under these same conditions, we also found that resveratrol altered the phosphorylation of several proteins involved in various biological processes, most notably transcriptional modulators, represented by p53, FOXA1, and AATF. Together these data provide a more comprehensive view of both the spectrum of phosphoproteins upon which resveratrol acts as well as the potential mechanisms by which it inhibits autophagy in serum-deprived cells.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalAutophagyChromatography, LiquidCulture Media, Serum-FreeHumansImmunoblottingMCF-7 CellsMechanistic Target of Rapamycin Complex 1Models, BiologicalMultiprotein ComplexesPhosphatidylinositol 3-KinasesPhosphopeptidesPhosphoproteinsPhosphorylationProteomeProteomicsAKT1 protein, humanAnti-Inflammatory Agents, Non-SteroidalCulture Media, Serum-FreeMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphatidylinositol 3-KinasesPhosphopeptidesPhosphoproteinsProteomeProto-Oncogene Proteins c-aktResveratrolribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaStilbenesTOR Serine-Threonine KinasesmTORC1phosphoproteomicsPRAS40resveratrolS6K1SILAC

Identifiers

PMID25311616
PMCPMC4258159
OpenAlexW2333814344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.